Keywords: teva, pays, 5m, active, bio, ms, drug

Teva pays $5M for Active Bio's MS drug

Article | 21 June 2004

Print This

Israel's Teva Pharmaceutical Industries and Active Biotech AB of Sweden have signed an agreement to develop and commercialize laquinimod, the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in